Continued use of afatinib with the addition of cetuximab after progression on afatinib in patients with EGFR mutation-positive non-small-cell lung cancer and acquired resistance to gefitinib or erlotinib
| Image |  |
|---|---|
| Description | scientific article published on 31 August 2017 |
| Author/s |
author: Scott Gettinger William Pao |
| Publication date | August 31, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |